The best clinical paper on multiple sclerosis in 2014

Abstract

Get full access to this article

View all access options for this article.

References

Ford

MacLennan

Avenell

. Cardiovascular disease and vitamin D supplementation: Trial analysis, systematic review, and meta-analysis. Am J Clin Nutr 2014; 100: 746–755.

Panitch

Hirsch

Haley

. Exacerbations of multiple sclerosis in patients treated with gamma interferon. Lancet 1987; 1: 893–895.

TNF neutralization in MS: Results of a randomized, placebo-controlled multicenter study. The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group. Neurology 1999; 53: 457–465.

Bolland

Grey

Gamble

. The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: A trial sequential meta-analysis. Lancet Diabetes Endocrinol 2014; 2: 307–320.

Autier

Boniol

Pizot

. Vitamin D status and ill health: A systematic review. Lancet Diabetes Endocrinol 2014; 2: 76–89.

Durup

Jorgensen

Christensen

. A reverse J-shaped association between serum 25-hydroxyvitamin D and cardiovascular disease mortality – the CopD-study. J Clin Endocrinol Metab. Epub ahead of print 24 February 2015. jc20144551.

Stein

Liu

Gray

. A randomized trial of high-dose vitamin D2 in relapsing–remitting multiple sclerosis. Neurology 2011; 77: 1611–1618.